Trade

with

Stryker Corporation
(NYSE: SYK)
AdChoices
83.53
+0.97
+1.17%
After Hours :
83.53
0.00
0.00%

Open

83.48

Previous Close

82.56

Volume (Avg)

1.20M (1.44M)

Day's Range

83.10-83.93

52Wk Range

71.22-86.93

Market Cap.

31.26B

Dividend Rate (Yield )

1.22 (1.48%)

Beta

0.96

Shares Outstanding

378.58M

P/E Ratio (EPS)

45.87 (1.80)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 9.02B

    • Net Income

    • 1.01B

    • Market Cap.

    • 31.26B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 7.40

    • PEG (Price/Earnings Growth) Ratio

    • 1.47

    • Beta

    • 0.96

    • Forward P/E

    • 16.08

    • Price/Sales

    • 3.40

    • Price/Book Value

    • 3.47

    • Price/Cash flow

    • 16.61

      • EBITDA

      • 1.56B

      • Return on Capital %

      • 4.35

      • Return on Equity %

      • 7.80

      • Return on Assets %

      • 4.35

      • Book Value/Share

      • 23.78

      • Shares Outstanding

      • 378.58M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.31 (9/26/2014)

      • Dividend Declaration Date

      • 7/21/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 87.67

        • Credit Rating

        • AA

        • Analysts

        • 10

        • EPS Estimate

        • 4.75

        • Cashflow Estimate

        • 5.79

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 6.80

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -22.50

          • -22.64

          • Net Income

            Q/Q (last year)

          • -39.90

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 6.07

          • 4.60

          • Net Income

            5-Year Annual Average

          • -2.60

          • -1.34

          • Dividends

            5-Year Annual Average

          • 22.42

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 66.50

            • 64.08

            • Pre-Tax Margin

            • 9.07

            • 15.19

            • Net Profit Margin

            • 7.40

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 67.50

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 20.20

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • 15.20

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.36

              • 0.34

              • Current Ratio

              • 2.53

              • 2.55

              • Quick Ratio

              • 1.68

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 1.91

              • 1.86

              • Book Value/Share

              • 23.78

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 45.05

                • 34.72

                • P/E Ratio 5-Year High

                • 48.39

                • 224.03

                • P/E Ratio 5-Year Low

                • 23.79

                • 60.23

                • Price/Sales Ratio

                • 3.34

                • 3.22

                • Price/Book Value

                • 3.41

                • 3.26

                • Price/Cash Flow Ratio

                • 16.61

                • 18.80

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 7.80

                    (16.50)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • 4.35

                    (10.90)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • 5.67

                    (14.50)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • 27.48k

                  • 34.11k

                  • Inventory Turnover

                  • 2.12

                  • 2.77

                  • Asset Turnover

                  • 0.59

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  1.26B
                  Operating Margin
                  13.92
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  16.61
                  Ownership

                  Institutional Ownership

                  74.03%

                  Top 10 Institutions

                  35.35%

                  Mutual Fund Ownership

                  35.34%

                  Float

                  88.68%

                  5% / Insider Ownership

                  1.45%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • VA CollegeAmerica AMCAP

                  •  

                    6,874,140

                  • 14.11

                  • 1.82

                  • VA CollegeAmerica Growth Fund of America

                  •  

                    6,778,376

                  • 0.00

                  • 1.79

                  • Vanguard Total Stock Mkt Idx

                  •  

                    4,835,541

                  • 4.67

                  • 1.28

                  • Franklin Rising Dividends

                  •  

                    4,804,727

                  • 0.00

                  • 1.27

                  • AMG Yacktman Fund

                  •  

                    4,400,000

                  • -4.62

                  • 1.16

                  • VA CollegeAmerica Cap World Gr and Inc

                  •  

                    3,581,000

                  • 4.40

                  • 0.95

                  • AMG Yacktman Focused Fund

                  •  

                    3,500,000

                  • -8.62

                  • 0.92

                  • Vanguard Five Hundred Index Fund

                  •  

                    3,105,014

                  • 1.38

                  • 0.82

                  • Vanguard Institutional Index Fund

                  •  

                    3,029,836

                  • 0.06

                  • 0.80

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Greenleaf Trust

                  •  

                    29,109,864

                  • -1.10%

                  • 7.69

                  • Capital Research Global Investors

                  •  

                    25,750,442

                  • +9.88%

                  • 6.80

                  • Vanguard Group, Inc.

                  •  

                    17,569,530

                  • +2.46%

                  • 4.64

                  • State Street Corp

                  •  

                    12,663,199

                  • +1.74%

                  • 3.34

                  • Yacktman Asset Management Co

                  •  

                    10,178,928

                  • -12.19%

                  • 2.69

                  • BlackRock Fund Advisors

                  •  

                    9,675,756

                  • +7.19%

                  • 2.56

                  • MFS Investment Management K.K.

                  •  

                    9,060,652

                  • +47.33%

                  • 2.39

                  • Walter Scott & Partners Ltd

                  •  

                    8,062,435

                  • +1.03%

                  • 2.13

                  • Franklin Advisers, Inc.

                  •  

                    6,201,517

                  • +0.09%

                  • 1.64

                  • J.P. Morgan Investment Management Inc.

                  •  

                    5,574,586

                  • +14.60%

                  • 1.47

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Slow Growth

                  Style

                  Large Growth

                  Stryker Corporation was incorporated in Michigan in 1946 as the successor company to a business founded in 1941. It is a medical technology company. The Company's products include implants used in joint replacement and trauma surgeri...morees; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties. The Company’s three reportable business segments are Reconstructive, MedSurg, and Neurotechnology and Spine. The Reconstructive segment includes orthopaedic reconstructive (hip and knee) and trauma implant systems as well as other related products. The MedSurg segment include surgical equipment and ...moresurgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical); reprocessed and remanufactured medical devices; as well as other medical device products used in a variety of medical specialties. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. The Company’s neurotechnology and Spine products include a comprehensive portfolio of products including both neurosurgical and neurovascular devices. Its neurotechnology offering includes products used for minimally invasive endovascular techniques, as well as a comprehensive line of products for traditional brain and open skull base surgical procedures, orthobiologic and biosurgery products including synthetic bone grafts and vertebral augmentation products, as well as minimally invasive products for the treatment of acute ischemic stroke. The Company also develops, manufactures and markets spinal implant products including cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. In the United States, most of the Company’s products are marketed directly to doctors, hospitals and other health-care facilities. The Company’s competitors in neurotechnology are Covidien and Micrus Endovascular, LLC and in spine products are Medtronic Sofamor Danek, Inc., and DePuy Spine, Inc. The Company’s businesses are subject to varying degrees of governmental regulation in the countries in which operations are conducted, and the general trend is toward increasingly stringent regulation.lessless

                  Key People

                  Mr. Kevin A. Lobo

                  CEO/Director/President

                  William U. Parfet

                  Director/Chairman of the Board

                  Mr. William R. Jellison

                  CFO/Vice President

                  Dean H. Bergy

                  Secretary/Vice President

                  Scott P. Bruder

                  Chief Medical Officer/Chief Scientific Officer/Vice President

                  • Stryker Corporation

                  • 2825 Airview Boulevard

                  • Kalamazoo, MI 49002

                  • USA.Map

                  • Phone: +1 269 385-2600

                  • Fax: +1 269 385-1062

                  • stryker.com

                  Incorporated

                  1946

                  Employees

                  25,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: